Literature DB >> 18977313

Do informed consent documents matter?

David B Resnik1.   

Abstract

This commentary argues that, despite extensive critiques of informed consent documents, there are several ethical and legal reasons for investigators and IRB members to take these documents seriously.

Entities:  

Mesh：

Year:  2008        PMID： 18977313      PMCID： PMC2670580          DOI： 10.1016/j.cct.2008.10.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN： 1551-7144            Impact factor:   2.226


  3 in total

1.  Readability standards for informed-consent forms as compared with actual readability.

Authors:  Michael K Paasche-Orlow; Holly A Taylor; Frederick L Brancati
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Consent documents for oncology trials: does anybody read these things?

Authors:  S Michael Sharp
Journal:  Am J Clin Oncol       Date:  2004-12       Impact factor: 2.339

3.  Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?

Authors:  S A Grossman; S Piantadosi; C Covahey
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544
  3 in total
  6 in total

1.  Audit of the informed consent process as a part of a clinical research quality assurance program.

Authors:  Pramod M Lad; Rebecca Dahl
Journal:  Sci Eng Ethics       Date:  2013-08-24       Impact factor: 3.525

2.  Evaluating the quality of information about alternatives to research participation in oncology consent forms.

Authors:  David B Resnik; Daniel Patrone; Shyamal Peddada
Journal:  Contemp Clin Trials       Date:  2009-11-06       Impact factor: 2.226

3.  The definition of placebo in the informed consent forms of clinical trials.

Authors:  Astrid Hernández; Josep-E Baños; Cristina Llop; Magí Farré
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

4.  A randomized trial comparing concise and standard consent forms in the START trial.

Authors:  Christine Grady; Giota Touloumi; A Sarah Walker; Mary Smolskis; Shweta Sharma; Abdel G Babiker; Nikos Pantazis; Jorge Tavel; Eric Florence; Adriana Sanchez; Fleur Hudson; Antonios Papadopoulos; Ezekiel Emanuel; Megan Clewett; David Munroe; Eileen Denning
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

5.  Challenges in informed consent decision-making in Korean clinical research: A participant perspective.

Authors:  Im-Soon Choi; Eun Young Choi; Iyn-Hyang Lee
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  How are US institutions implementing the new key information requirement?

Authors:  Jessica Mozersky; Matthew P Wroblewski; Erin D Solomon; James M DuBois
Journal:  J Clin Transl Sci       Date:  2020-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.